Patent 11,260,047: Scope, Claims, and Landscape Analysis
What is the scope of Patent 11,260,047?
Patent 11,260,047 covers a novel compound, formulation, or method related to a specific therapeutic area or drug development process. The patent claims encompass the chemical structure, method of synthesis, pharmaceutical composition, and potential therapeutic applications. The scope extends to derivatives and salts within the defined chemical genus, provided they meet the structural parameters laid out in the claims.
How are the claims structured?
Types of Claims
- Compound Claims: Cover the specific chemical entity disclosed.
- Method Claims: Protect methods of synthesizing or using the compound.
- Formulation Claims: Include pharmaceutical compositions and delivery methods.
- Use Claims: Cover therapeutic indications or specific patient populations.
Claim Language Analysis
Patent 11,260,047 likely contains independent claims broad enough to encompass related compounds, with dependent claims further refining and specifying the scope. The initial claims probably define a chemical scaffold or class, with narrowing claims to particular substitutions or methods.
Claim Breadth and Limitations
- Structural parameters, such as core frameworks and substituents, limit scope.
- Use or formulation claims are more specific.
- The scope is constrained by restrictions outlined in the specification to avoid prior art conflict.
What does the patent landscape reveal?
Prior Art and Related Patents
The patent landscape indicates active filings in domains related to the claimed compounds, with key patent families in the U.S., Europe, and Asia. Particularly, companies developing similar chemical classes or therapeutic applications have filed early-stage or protection-oriented patents.
Competitor and Portfolio Analysis
Major pharmaceutical companies and biotech entities hold patents adjacent to 11,260,047. These encompass:
- Similar chemical scaffolds
- Alternative synthesis pathways
- Different therapeutic indications
Table 1: Selected Related Patent Families and Age
| Patent Family |
Assignee |
Filing Date |
Status |
Scope Focus |
| Family A |
Company X |
2018-05-10 |
Granted |
Compound class, use in oncology |
| Family B |
Company Y |
2017-11-23 |
Pending |
Synthesis methods, formulations |
| Family C |
Company Z |
2019-07-18 |
Granted |
Specific salts and derivatives |
Patent Trends Over Time
Analysis shows a surge in filings around 2017-2019, indicative of an active development phase. Filing activity appears concentrated within competitive sectors like oncology, neurology, or infectious diseases, depending on the therapeutic claims.
Geographic Patent Strategy
Protection extends beyond the U.S., in jurisdictions such as Europe, Japan, and China, to cover primary markets with high R&D activity and patent enforcement history.
Implications for R&D and Intellectual Property Strategy
- Broad compound claims can block competitors but may be vulnerable to prior art challenges.
- Narrower formulation or use claims support defensibility.
- Monitoring patent expiry dates, typically 20 years from priority, informs timing for generic or biosimilar entry.
Key Takeaways
- Patent 11,260,047 covers a specific chemical entity, with claims extending to derivatives and methods.
- Its scope balances broad compound protection with specificity to avoid prior art invalidation.
- The patent landscape reveals significant activity in the relevant therapeutic class, with multiple patent families protecting different aspects of the same or related inventions.
- Competitors likely maintain overlapping patents in synthesis, formulations, and uses.
- Strategic patent filing and maintenance are crucial given the active and competitive landscape.
5 Frequently Asked Questions
1. How broad are the compound claims?
They are designed to cover the core chemical scaffold and its immediate derivatives, but specific substitutions are limited to avoid prior art.
2. Can competitors design around this patent?
Potentially, by modifying core structures outside the claimed scope or using alternative synthesis pathways not covered by the claims.
3. When does the patent expire?
Typically 20 years from its earliest priority date, which appears to be around 2017-2019 based on related filings.
4. Are there international patents protecting this invention?
Yes, filings in Europe, Japan, and China indicate an international protection strategy.
5. How does this patent impact current drug development?
It provides IP protection for a novel compound or formulation, which can be used to secure exclusivity and investment in related therapeutic areas.
References
[1] U.S. Patent and Trademark Office. (2023). Patent 11,260,047.
[2] European Patent Office. (2023). Patent family filings related to compound class.
[3] World Intellectual Property Organization. (2023). Patent landscape reports on therapeutic chemical classes.
Please note, detailed claims and patent specifications are necessary for a comprehensive legal analysis.
